7
IRUS Total
Downloads
  Altmetric

543P Neoadjuvant MRx0518 treatment is associated with significant gene and metagene signature changes in solid tumours

File Description SizeFormat 
FInal ESMO abstract MRx0518.docxAccepted version29.11 kBMicrosoft WordView/Open
Title: 543P Neoadjuvant MRx0518 treatment is associated with significant gene and metagene signature changes in solid tumours
Authors: Lythgoe, M
Adriani, M
Stebbing, J
Clark, J
Pickford, E
Frampton, A
Liu, D
Kyrgiou, M
Rees, E
Fyvie, G
Stevenson, A
Krell, J
Item Type: Journal Article
Issue Date: Sep-2021
URI: http://hdl.handle.net/10044/1/91877
DOI: 10.1016/j.annonc.2021.08.1065
ISSN: 0923-7534
Publisher: Elsevier BV
Start Page: S607
End Page: S607
Journal / Book Title: Annals of Oncology
Volume: 32
Copyright Statement: © 2021 Elsevier Ltd. All rights reserved. This manuscript is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International Licence http://creativecommons.org/licenses/by-nc-nd/4.0/
Keywords: 1112 Oncology and Carcinogenesis
Oncology & Carcinogenesis
Publication Status: Published
Appears in Collections:Department of Surgery and Cancer
Faculty of Medicine



This item is licensed under a Creative Commons License Creative Commons